LumiThera, Inc.: Photobiomodulation Therapy for Dry AMD: Insights from 4.5 Years of Follow-up from the LIGHTSITE IIIB Trial

Location: Room 252AB
Date & Time: Saturday, 6th September, 10:15 – 11:15 CEST
Chairperson(s): Q. Dong Nguyen, USA

Speakers:

Presentations:

Q. Dong Nguyen, USA

10:15  Welcome & Introductions

Q. Dong Nguyen, USA

10:20  Photobiomodulation Therapy: Proposed Mechanisms for Ocular Disease and Injury

D. Do, USA

10:30  Clinical Findings from the LIGHTSITE III and IIIB Extension Trials

M. Munk, SWITZERLAND

10:45  Supporting Evidence for Photobiomodulation Use in Ocular Conditions

Q. Dong Nguyen, USA

11:00  Q&A Discussion

Back to Main Programme